IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host

被引:38
作者
Liu, Xiao Song [1 ]
Leerberg, Joanne [1 ]
MacDonald, Kelli [2 ]
Leggatt, Graham R. [1 ]
Frazer, Ian H. [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Program Immunol, Brisbane, Qld, Australia
[2] Queensland Inst Med Res, Bone Marrow Transplantat Lab, Herston, Qld 4006, Australia
基金
英国医学研究理事会;
关键词
VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; DENDRITIC CELLS; E7; ONCOPROTEIN; CTL EPITOPES; IN-VIVO; IMMUNITY; IMMUNOTHERAPY; INFECTION;
D O I
10.4049/jimmunol.0802047
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Ags characterizing tumors or chronic viral infection are generally presented to the host immune system before specific immunotherapy is initiated, and consequent generation of regulatory CD4(+) T cells can inhibit induction of desired effector CD8 T cell responses. IL-10 produced in response to ongoing Ag exposure inhibits generation of CD8 T cells in an Ag-experienced host. We now show that this IL-10 is produced by Ag experienced CD4(+) glucocorticoid-induced tumor necrosis factor receptor(+) T cells that also secrete IFN-gamma upon antigenic stimulation, that IL-10 secretion by these cells is enhanced through IFN-gamma signaling, and, unexpectedly, that IFN-gamma signaling is required for inhibition of generation of Ag-specific CD8 T cell responses in an Ag-experienced host. Systemic inhibition of both IL-10 and IFN-gamma at the time of immunization may therefore facilitate induction of effective immunotherapeutic responses against tumor specific and viral Ags. The Journal of Immunology, 2009, 183: 51-58.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 36 条
[1]
CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis [J].
Anderson, Charles F. ;
Oukka, Mohammed ;
Kuchroo, Vijay J. ;
Sacks, David .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :285-297
[2]
IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy [J].
Berner, Vanessa ;
Liu, Haiyan ;
Zhou, Qing ;
Alderson, Kory L. ;
Sun, Kai ;
Weiss, Jonathan M. ;
Back, Timothy C. ;
Longo, Dan L. ;
Blazar, Bruce R. ;
Wiltrout, Robert H. ;
Welniak, Lisbeth A. ;
Redelman, Doug ;
Murphy, William J. .
NATURE MEDICINE, 2007, 13 (03) :354-360
[3]
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection [J].
Brooks, David G. ;
Lee, Andrew M. ;
Elsaesser, Heidi ;
McGavern, Dorian B. ;
Oldstone, Michael B. A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (03) :533-541
[4]
Interleukin-10 determines viral clearance or persistence in vivo [J].
Brooks, David G. ;
Trifilo, Matthew J. ;
Edelmann, Kurt H. ;
Teyton, Luc ;
McGavern, Dorian B. ;
Oldstone, Michael B. A. .
NATURE MEDICINE, 2006, 12 (11) :1301-1309
[5]
USE OF HUMAN PAPILLOMAVIRUS TYPE-6 CAPSIDS TO DETECT ANTIBODIES IN PEOPLE WITH GENITAL WARTS [J].
CARTER, JJ ;
WIPF, GC ;
HAGENSEE, ME ;
MCKNIGHT, B ;
HABEL, LA ;
LEE, SK ;
KUYPERS, J ;
KIVIAT, N ;
DALING, JR ;
KOUTSKY, LA ;
WATTS, DH ;
HOLMES, KK ;
GALLOWAY, DA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :11-18
[6]
IL-10: The master regulator of immunity to infection [J].
Couper, Kevin N. ;
Blount, Daniel G. ;
Riley, Eleanor M. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5771-5777
[7]
Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines [J].
Da Silva, DM ;
Pastrana, DV ;
Schiller, JT ;
Kast, WM .
VIROLOGY, 2001, 290 (02) :350-360
[8]
Type IIFN negatively regulates CD8+ T cell responses through IL-10-Producing CD4+ T regulatory 1 cells [J].
Dikopoulos, N ;
Bertoletti, A ;
Kröger, A ;
Hauser, H ;
Schirmbeck, R ;
Reimann, J .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :99-109
[9]
Cure of chronic viral infection by neutralizing antibody treatment [J].
Ejrnaes, Mette ;
von Herrath, Matthias G. .
AUTOIMMUNITY REVIEWS, 2007, 6 (05) :267-271
[10]
VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS [J].
FELTKAMP, MCW ;
SMITS, HL ;
VIERBOOM, MPM ;
MINNAAR, RP ;
DEJONGH, BM ;
DRIJFHOUT, JW ;
TERSCHEGGET, J ;
MELIEF, CJM ;
KAST, WM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2242-2249